Bipartisan Support And Nuclear Restarts Will Unlock Markets

Published
06 Aug 24
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
US$333.84
3.5% undervalued intrinsic discount
14 Aug
US$322.23
Loading
1Y
69.6%
7D
-4.0%

Author's Valuation

US$333.8

3.5% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on07 May 25
Fair value Increased 17%

Shared on30 Apr 25
Fair value Decreased 3.33%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25
Fair value Decreased 2.76%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on16 Apr 25
Fair value Decreased 7.09%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25
Fair value Increased 5.03%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Decreased 3.45%

Shared on26 Mar 25
Fair value Increased 1.00%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on10 Mar 25
Fair value Increased 4.19%

AnalystConsensusTarget has increased revenue growth from 0.5% to 1.8%, decreased profit margin from 13.4% to 10.7% and increased future PE multiple from 31.6x to 44.1x.